José Rodríguez

Interferon-α2a in the Treatment of Chronic Myeloid Leukemia: Results of the Spanish Group on Interferon-α2a in CML

J. Steegmann, A. Alegre, M. Giralt, 1992 .

GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study

Jordi Martínez, A. Palacios, A. Gutiérrez, 2007, European journal of haematology.

Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome

H. Kantarjian, G. Garcia-Manero, F. Ravandi, 2018, Hematological oncology.

Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

J. Carles, H. Scher, J. Bono, 2012 .

Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302.

J. Carles, H. Scher, J. Bono, 2014 .